Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873204 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL32678404 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL14841540 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL8738678 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL19718040 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18138230 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24534431 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17836881 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL1773862 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL3502857 | 1.00 | ALOX15 (0.65) | ALOX15ALDH1A1LMNATHRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3672692-B1 | BLENDS CONTAINING ENANTIOMERICALLY PURE AMBROCENIDE® | SYMRISE AG (DE) | 2023-08-16 | — | — | EP | claimed |
| US-11091723-B2 | Use of ambrocenide® for intensifying a lily of the valley scent | SYMRISE AG (DE) | 2021-08-17 | — | — | US | claimed |
| US-11066625-B2 | Blends containing enantiomerically pure Ambrocenide® | SYMRISE AG (DE) | 2021-07-20 | — | — | US | claimed |
| US-20200239810-A1 | USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT | SYMRISE AG (DE) | 2020-07-30 | — | — | US | claimed |
| US-20200172830-A1 | BLENDS CONTAINING ENANTIOMERICALLY PURE AMBROCENIDE® | SYMRISE AG (DE) | 2020-06-04 | — | — | US | claimed |
| EP-2947078-B1 | Novel mixtures with (4aR, 5R, 7aS, 9R) -octahydro-2,2,5,8,8,9a-hexamethyl-4h-4a, 9-methanoazuleno (5,6-d) -1,3-dioxol) (ambrocenide ®) | SYMRISE AG (DE) | 2018-03-21 | — | — | EP | claimed |
| US-12529008-B2 | Natural semi-solid perfume | EXPRESSIONS PARFUMEES (FR) | 2026-01-20 | — | — | US | disclosed |
| EP-3749281-B1 | PERFUMING COMPLEX AND COMPOSITION OF PERFUMED WATER | EXPRESSIONS PARFUMEES (FR) | 2024-06-26 | — | — | EP | disclosed |
| US-11965144-B2 | Perfume complex and perfumed water composition | EXPRESSIONS PARFUMÉES (FR) | 2024-04-23 | — | — | US | disclosed |
| WO-2023170261-A1 | READY-FOR-USE MILKY, VISCOUS AND STICKY PERFUME COMPLEX AND ASSOCIATED PERFUMED COMPOSITION | EXPRESSIONS PARFUMEES (FR) | 2023-09-14 | — | — | WO | disclosed |
| EP-3672692-B1 | BLENDS CONTAINING ENANTIOMERICALLY PURE AMBROCENIDE® | SYMRISE AG (DE) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023067179-A1 | FRAGRANCING COMPLEX, FRAGRANCING COMPOSITION AND FRAGRANCED AQUEOUS COMPOSITION OF NATURAL ORIGIN | EXPRESSIONS PARFUMEES (FR) | 2023-04-27 | — | — | WO | disclosed |
| US-20230043162-A1 | NATURAL SEMI-SOLID PERFUME | EXPRESSIONS PARFUMEES (FR) | 2023-02-09 | — | — | US | disclosed |
| US-20210230502-A1 | PERFUME COMPLEX AND PERFUMED WATER COMPOSITION | EXPRESSIONS PARFUMÉES (FR) | 2021-07-29 | — | — | US | disclosed |
| US-11066625-B2 | Blends containing enantiomerically pure Ambrocenide® | SYMRISE AG (DE) | 2021-07-20 | — | — | US | disclosed |
| WO-2021123110-A1 | SEMI-SOLID NATURAL PERFUME | EXPRESSIONS PARFUMEES (FR) | 2021-06-24 | — | — | WO | disclosed |
| EP-3749281-A1 | PERFUME COMPLEX AND SCENTED WATER COMPOSITION | Expressions Parfumees (FR) | 2020-12-16 | — | — | EP | disclosed |
| WO-2019154892-A1 | PERFUME COMPLEX AND SCENTED WATER COMPOSITION | EXPRESSIONS PARFUMÉES (FR) | 2019-08-15 | — | — | WO | disclosed |
| EP-3471691-A1 | MIXTURE COMPRISING AT LEAST DIHYDRO-5-PENTYL-2(3H)-FURANONE AND 2,4-DIMETHYL-4-PHENYLTETRAHYDROFURAN AND USE THEREOF FOR MASKING UNPLEASANT ODOURS | Expressions Parfumees (FR) | 2019-04-24 | — | — | EP | disclosed |
| WO-2017216478-A1 | MIXTURE COMPRISING AT LEAST DIHYDRO-5-PENTYL-2(3H)-FURANONE AND 2,4-DIMETHYL-4-PHENYLTETRAHYDROFURAN AND USE THEREOF FOR MASKING UNPLEASANT ODOURS | EXPRESSIONS PARFUMEES (FR) | 2017-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172830-A1 | BLENDS CONTAINING ENANTIOMERICALLY PURE AMBROCENIDE® | OR51E2, CYP1B1, QDPR | ALOX15 465/4885ALDH1A1 431/4885LMNA 3423/4885 |
| US-20230043162-A1 | NATURAL SEMI-SOLID PERFUME | TES, DSG1, CUTA | ALOX15 576/4885ALDH1A1 2665/4885LMNA 4636/4885 |
| US-20200239810-A1 | USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT | OR51E2, OR10J3, ALG3 | ALOX15 710/4885ALDH1A1 1767/4885LMNA 3395/4885 |
| US-11091723-B2 | Use of ambrocenide® for intensifying a lily of the valley scent | OR51E2, OR10J3, TRPA1 | ALOX15 585/4885ALDH1A1 1494/4885LMNA 3625/4885 |
| US-11066625-B2 | Blends containing enantiomerically pure Ambrocenide® | OR51E2, CYP1B1, QDPR | ALOX15 465/4885ALDH1A1 431/4885LMNA 3423/4885 |
| US-12529008-B2 | Natural semi-solid perfume | TES, TAS2R50, TAS2R10 | ALOX15 879/4885ALDH1A1 1674/4885LMNA 4729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.